grasp-af the national picture vanessa brown national improvement lead ian robson senior analyst
TRANSCRIPT
GRASP-AFThe National Picture
Vanessa BrownNational Improvement Lead
Ian RobsonSenior Analyst
Outline
• AF and stroke• Objective• Management of stroke risk• Changes to QOF• GRASP-AF practical demonstration• Q & A
Stroke is a frequent complication of AF
• Stroke is the leading complication of AF
• Patients with AF have a five-fold higher stroke risk than those without AF1
• AF doubles the risk of stroke when adjusted for other risk factors2
• Without preventive treatment, each year approximately 1 in 20 patients (5%) with AF will have a stroke3
• It is estimated that 15% of all strokes are caused by AF5 and that 12,500 strokes per year in England are directly attributable to AF6
1. NICE clinical guideline 36.June 2006. Available at http://www.nice.org.uk/guidance/CG36/?c=91497; accessed April 2010; 2. ACC/AHA/ESC guidelines: Fuster V et al. Circulation 2006;114:e257–354 & Eur Heart J 2006;27:1979–2030; 3. Atrial Fibrillation Investigators. Arch Intern Med 1994;154:1449–57; 4. Carlson M. Medscape Cardiology. 2004;8; available at http://cme.medscape.com; accessed Feb 2010; 5. Lip GYH, Lim HS. Lancet Neurol 2007;6:981-93; 6. NHS Improvement. June 2009. Available at http://www.improvement.nhs.uk/heart/Portals/0/documents2009/AF_Commissioning_Guide_v2.pdf; accessed April 2010
Stroke is a serious complication of AF
• Stroke in AF is associated with a heavy burden of morbidity and mortality
• AF related stroke is usually more severe than stroke due to other causes1
• Compared with other stroke patients, those with AF are more likely to:– Have cortical deficit (e.g. aphasia), severe limb weakness
and diminished alertness, and be bedridden on admission2
– Have longer in-hospital stay with a lower rate of discharge to their own home3
1. Savelieva I et al. Ann Med 2007;39:371–91; 2. Dulli DA et al. Neuroepidemiology 2003;22:118–23; 3. NICE clinical guideline 36.June 2006. Available at http://www.nice.org.uk/guidance/CG36/?c=91497; accessed April 2010; 4. Benjamin EJ et al. Circulation 1998;98:946–52
Objective: To reduce the number of strokes caused by AF
• Improved detection and diagnosis– Raised awareness– Promote opportunistic detection
• Ensure optimal treatment for those diagnosed with AF
– Improved assessment of risk- CHADS2, CHA2DS2-VASc
– Appropriate management of risk- GRASP-AF– Improve anticoagulation services
The GRASP-AF Toolto improve the management of AF
• Identifies patients on your system with diagnosed atrial fibrillation
• Searches for co-morbidities and works out both a CHADS2 and CHA2DS2-VASc score
• Searches for current medication– warfarin, aspirin or newer oral anticoagulant
• Searches for recorded reasons for NOT treating with warfarin• Gives a simple alert for those at high risk and not on warfarin or
newer oral anticoagulant
QOF changes for 2012 / 13
Old target
AF3
The percentage of patients with atrial fibrillation who are currently
treated with anti-coagulant drug therapy or an anti-platelet drug
therapy
QOF changes for 2012 / 13
New targets
AF5
The percentage of patients with Atrial Fibrillation in whom stroke risk
has been assessed using the CHADS2 risk stratification scoring
system in the preceding 15 months
QOF changes for 2012 / 13
New targets
AF6
In those patients with Atrial Fibrillation in whom there is a record of a
CHADS2 score of 1, the percentage of patients who are currently
treated with anti-coagulation drug therapy or an anti-platelet therapy
AF7
In those patients with Atrial Fibrillation in whom there is a record of a
CHADS2 score of greater than 1, the percentage of patients who are
currently treated with anti-coagulation drug therapy
Ian RobsonSenior Analyst, NHS Improvement
• Demonstration of GRASP-AF• Live demonstration of CHART Online
The GRASP-AF tool
What is it?
Uses free / commonly used software
A series of searches of a GPs clinical system
Looks at patients with a history of AF
Then looks at their medication and other relevant medical history
Gives a practice over view – Dashboard
Gives a patient list
The GRASP-AF tool
CHADS2 / CHA2DS2-VASc
Risk Factor CHADS2 CHA2DS2-VASc
Cardiac failure 1
Congestive HF / LVSD 1
Hypertension 1 1
Diabetes 1 1
Stroke or TIA 2 2
Age 65 - 74 1
Age >75 1 2
Female 1
The GRASP-AF tool
The GRASP-AF tool
The GRASP-AF tool
QOF changes for 2012 / 13
New targets
AF6
In those patients with Atrial Fibrillation in whom there is a record of a
CHADS2 score of 1, the percentage of patients who are currently
treated with anti-coagulation drug therapy or an anti-platelet therapy
AF7
In those patients with Atrial Fibrillation in whom there is a record of a
CHADS2 score of greater than 1, the percentage of patients who are
currently treated with anti-coagulation drug therapy
The GRASP-AF tool
The GRASP-AF tool
The GRASP-AF tool
What changes have been made?
626 practices uploaded more than once
2.32% increase in high risk patients on anticoagulation
68 AF-related strokes prevented
35 if population standardised
5.73% increase in high risk patients coded as anticoagulation
contraindicated / declined
The GRASP-AF tool
Future projections
In all 1,746 practices that have uploaded data:
55.35% high risk patients on anticoagulation
35.90% high risk patients on antiplatelet
8.75% high risk patients on nothing
14.05% high risk patients coded as anticoagulation contraindicated /
Declined
Current treatment prevents 2,180 AF-related strokes / 1,482 deaths
The GRASP-AF tool
Future projections
If all 1,746 practices that have uploaded data:
85% high risk patients on anticoagulation
0% high risk patients on antiplatelet
15% high risk patients anticoagulation contraindicated / declined
This treatment would prevent 2,743 AF-related strokes
An increase of 564
Would prevent an extra 383 deaths
More Information
Can be found at http://www.improvement.nhs.uk/graspaf/
E-mail support:
Support for practices, networks and other organisations working with GRASP-AF
Contact [email protected] with your query
Any Questions?